Similar to our findings, restoring Nrf2 in MCD mice alleviated the hepatic phenotype toward a reduction in hepatic steatosis, mainly by activating PPARα and suppressing SREBP1 [13]. The gene discussed is NFE2L2; the disease is Hepatic steatosis.